.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Please enable Javascript to use all features and improve your user experience.

Abstractvortrag
V377

Die Applikation von Interleukin-4 reduziert den Sekundärschaden nach experimentellem Schädel-Hirn-Trauma im Mausmodell

The administration of Interleukin-4 ameliorates secondary brain damage after experimental traumatic brain injury in mice

Appointment

Date: 28/06/2023

Time: 12:20 – 12:25

Talk time: 4 Min.

Discussion time: 1 Min.

Location / Stream:

Session

Rapid Communication – SHT und ICP monitoring

Topic

Neurotrauma und Intensivmedizin

Authors

Johannes Walter (Heidelberg), Samuel Hutagalung (Heidelberg), Jannis Mende (Heidelberg), Christa Maurer (Heidelberg), Joachim Kirsch (Heidelberg), Thomas Skutella (Heidelberg), Klaus Zweckberger (Braunschweig), Andreas W. Unterberg (Heidelberg), Alexander Younsi (Heidelberg)